Building a Foundation: Understanding Your MLASA Diagnosis

Getting a diagnosis of Mitochondrial Myopathy, Lactic Acidosis, and Sideroblastic Anemia (MLASA) can be overwhelming ^[1]. After months or years of searching for answers to unexplained fatigue or weakness, you finally have a name for what is happening. Because MLASA is an ultra-rare condition, it is common for local doctors to have never encountered it before ^[1]. This page will help you understand the core components of the disease and what this diagnosis means for your journey ahead.

An Exceptionally Rare Condition

MLASA is one of the rarest mitochondrial disorders known to medicine. To give you a sense of its rarity, historical estimates from a 2019 review identified only 11 reported cases of MLASA1 (the subtype caused by the PUS1 gene) in medical literature worldwide at that time ^[1]. While other subtypes like MLASA2 (caused by the YARS2 gene) have more documented cases, the total number remains very small ^[2][3].

Because so few people have this condition, there is no “standard” experience. Every person’s journey is unique, and researchers are still learning about the full spectrum of the disease ^[4].

Understanding the “Core Triad”

The name MLASA describes a “triad” of three main medical issues that often occur together. However, not every patient will have all three at the same time, especially early in the disease ^[5][6].

1. Mitochondrial Myopathy

Mitochondrial myopathy is muscle weakness caused by a “power failure” in the cells.

• The Cause: Your mitochondria (the “power plants” of your cells) cannot efficiently turn food and oxygen into energy ^[7].
• What it feels like: This typically shows up as exercise intolerance, where muscles tire very quickly, or a general sense of physical weakness ^[8]. In some cases, it can eventually affect the muscles used for breathing ^[6].

2. Lactic Acidosis

Lactic acidosis occurs when a substance called lactic acid builds up in the blood.

• The Cause: When mitochondria cannot produce energy normally, the body switches to a less efficient backup system that creates lactic acid as a byproduct ^[7][8].
• What it means: While many patients have high lactate levels, severe spikes typically show up during times of illness or intense physical stress ^[6][5].

3. Sideroblastic Anemia

Sideroblastic anemia is a specific type of anemia (low red blood cell count) where the body cannot properly incorporate iron into hemoglobin ^[9].

• The “Ring”: The energy failure affects the nucleated red blood cell precursors in your bone marrow. When doctors look at this marrow under a microscope, they see ring sideroblasts—developing red blood cells where iron has piled up in a ring around the center because the mitochondria couldn’t use it ^[9][10].
• What it feels like: Anemia can cause pale skin, dizziness, and intense fatigue because your blood isn’t carrying enough oxygen to your organs ^[11].

When Does MLASA Begin?

The onset of MLASA varies depending on the genetic subtype, but it most commonly begins in childhood.

• Childhood Onset: For many, symptoms appear in the first decade of life. For the YARS2 subtype (MLASA2), the median age when symptoms are first noticed is approximately 1.5 years based on small cohorts, though this does not predict an individual’s onset ^[4].
• Adult Onset: Though less common, some individuals do not experience significant symptoms until adulthood ^[3]. In these cases, the disease might be triggered or worsened by a separate illness or even pregnancy ^[5][4].

The Journey Ahead

MLASA can be a progressive condition, meaning symptoms may change or become more pronounced over time, though manifestations may progress at different rates ^[11][1]. In the YARS2 subtype, research has shown that survival rates can be high in childhood (94% at age 10), but the risk of complications like heart muscle thickening (hypertrophic cardiomyopathy) or breathing difficulties increases as patients get older ^[2][6].

Because of the risks to the heart and lungs, specialists often recommend regular monitoring of these systems starting from the time of diagnosis ^[6][2]. While the rarity of the condition can feel isolating, understanding these core components is the first step toward building a specialized care team that can monitor your health and manage symptoms effectively.